Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Go back to Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 62.20 +2.85 (4.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.35 | 52 Week High | $0.52 | |||
| Open | $60.26 | 52 Week Low | $0.08 | |||
| Day High | $62.73 | P/E | N/A | |||
| Day Low | $58.34 | EPS | $-3.80 | |||
| Volume | 1,285,351 | |||||
